Your cart is empty
Your cart is currently empty. Let us assist you in finding the right product.
UGAXIS-P combines a probiotic, a postbiotic, beta-glucan, lycopene, and beta-sitosterol. The house describes microencapsulated technology with tributyrin to reduce prostate congestion, a rise in Q-max of 3–4 ml/sec, an IPSS reduction of 4–6 points, and more stable PSA.
MRP ₹450
UGAXIS-P is the urology brand the house describes as first in India, and the composition explains why it cannot be filed as another alpha blocker. The vegetarian capsule brings Limosilactobacillus reuteri 1 billion CFU, beta-sitosterol 150 mg, lycopene 10 mg, boron proteonate 5 mg, tributyrin 100 mg, zinc gluconate 10 mg, selenium 100 mcg, and beta-glucan 50 mg. The lead calls this a probiotic, a postbiotic, beta-glucan, lycopene, and beta-sitosterol, and it describes microencapsulated technology with tributyrin to reduce prostate congestion. The pack is 3 × 10 N veg capsules. The dose is once daily. The MRP is ₹450. Every one of those lines is checkable. A shorter “prostate nutraceutical” blurb is not.
The house also describes a rise in Q-max of 3–4 ml/sec, an IPSS reduction of 4–6 points, and more stable PSA. This page repeats that description and does not convert it into an independent trial. The indications are BPH, LUTS, and prostatitis, support for urinary flow and LUTS, and support for PSA levels. “Support” is the house’s verb. It is weaker than “treats”, and the weakness is the accurate reading. Do not tighten it in a brochure because the flag sounds strong. First in India is the house’s flag for this brand alone. It does not extend to SILUTS-D8, which is merely featured, or to SENSIMIST, which carries a different superlative in a different lane.
Because the capsule is not silodosin, tamsulosin, or alfuzosin, it does not inherit their dose cautions and they do not inherit its Q-max sentence. A man may be a candidate, in a physician’s judgement, for more than one of these brands. The catalogue will not make that judgement, and the cart will not notice if you add both. If you add both, the enquiry should say why, in the organisation’s own words, not in a blended claim. Once daily is the published dose. It is not “once daily after a meal”; that meal line belongs to SILUTS-4 and SILUTS-8. Copying it here would be tidy and wrong.
The pack count, 3 × 10, is easy to mishear as 10 × 10, which is the count on several tablet brands. Say three strips of ten vegetarian capsules. Say ₹450. Say the flag is the house’s. The photograph is the real pack. There is no need to restage the capsule with herbs, even though the composition is nutritional as well as microbial. The lane is still urology. The general lane remains empty, and UGAXIS-P is not the product that fills it. It has a prostate indication and a urology address. Leave it there.
Your cart is currently empty. Let us assist you in finding the right product.
Cookie preferences